These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 2106200

  • 1. Etoposide in remission induction of adult acute myeloid leukemia.
    Leoni F, Ciolli S, Patriarchi S, Morfini M, Rossi Ferrini P.
    Acta Haematol; 1990; 83(2):82-5. PubMed ID: 2106200
    [Abstract] [Full Text] [Related]

  • 2. Therapy of acute myelogenous leukemia in adults.
    Petti MC, Broccia G, Caronia F, Di Raimondo F, Fioritoni G, Ladogana S, Leone G, Liso V, Musso M, Neri A.
    Haematol Blood Transfus; 1990; 33():249-53. PubMed ID: 2182417
    [No Abstract] [Full Text] [Related]

  • 3. Acute myeloid leukemia complicating multiple myeloma: a case successfully treated with etoposide, thioguanine, and cytarabine.
    Erikci AA, Ozturk A, Tekgunduz E, Sayan O.
    Clin Lymphoma Myeloma; 2009 Aug; 9(4):E14-5. PubMed ID: 19717372
    [Abstract] [Full Text] [Related]

  • 4. Treatment of acute myelogenous leukemia in patients over 50 years of age with V-TAD: a Southwest Oncology Group study.
    Bigelow CL, Kopecky K, Files JC, Head D, Lipschitz DA, Grever M, Appelbaum FR.
    Am J Hematol; 1995 Apr; 48(4):228-32. PubMed ID: 7717369
    [Abstract] [Full Text] [Related]

  • 5. Intensive induction and consolidation chemotherapy for adults and children with acute myeloid leukaemia (AML) joint AML trial 1982-1985.
    Marcus RE, Catovsky D, Prentice HG, Newland AC, Chessells JM, Stevens RF, Hann IM, Goldman JM, Hoffbrand AV, Galton DA.
    Haematol Blood Transfus; 1987 Apr; 30():346-51. PubMed ID: 2442074
    [No Abstract] [Full Text] [Related]

  • 6. Intensively timed combination chemotherapy for the induction of adult patients with acute myeloid leukemia: long-term follow-up of a phase 2 study.
    Rytting M, Ravandi F, Estey E, Cortes J, Faderl S, Garcia-Manero G, Jeha S, Ouzounian S, Pierce S, Kantarjian H.
    Cancer; 2010 Nov 15; 116(22):5272-8. PubMed ID: 20665501
    [Abstract] [Full Text] [Related]

  • 7. Improved treatment results in the myelocytic subtypes FAB M1-M4 but not in FAB M5 after intensification of induction therapy: results of the German childhood AML studies BFM-78 and BFM-83.
    Ritter J, Creutzig U, Schellong G.
    Haematol Blood Transfus; 1990 Nov 15; 33():185-92. PubMed ID: 2182410
    [No Abstract] [Full Text] [Related]

  • 8. [Intensification of chemotherapy of acute myeloid leukemia in children: report on the studies of the AML-BFM 78 and AML-BFM 83 protocols].
    Creutzig U, Ritter I, Schellong G.
    Gematol Transfuziol; 1991 Jan 15; 36(1):16-21. PubMed ID: 2065939
    [No Abstract] [Full Text] [Related]

  • 9. Long-term follow-up of a randomized post-induction therapy trial in acute myelogenous leukemia (a Southeastern Cancer Study Group trial).
    Volger WR, Weiner RS, Moore JO, Omura GA, Bartolucci AA, Stagg M.
    Leukemia; 1995 Sep 15; 9(9):1456-60. PubMed ID: 7544851
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of acute myelogenous leukemia in children: results of the Italian Cooperative Study AIEOP/LAM 8204.
    Amadori S, Ceci A, Comelli A, Madon E, Masera G, Nespoli L, Paolucci G, Zanesco L, Covelli A, Mandelli F.
    J Clin Oncol; 1987 Sep 15; 5(9):1356-63. PubMed ID: 3476689
    [Abstract] [Full Text] [Related]

  • 13. Aclarubicin plus cytosine arabinoside versus daunorubicin plus cytosine arabinoside in previously untreated patients with acute myeloid leukemia: a Danish national phase III trial. The Danish Society of Hematology Study Group on AML, Denmark.
    Hansen OP, Pedersen-Bjergaard J, Ellegaard J, Brincker H, Boesen AM, Christensen BE, Drivsholm A, Hippe E, Jans H, Jensen KB.
    Leukemia; 1991 Jun 15; 5(6):510-6. PubMed ID: 2056774
    [Abstract] [Full Text] [Related]

  • 14. [Effect of etoposide added to individualized induction therapy of adult acute myeloid leukemia--the JALSG-AML-92 Study. Japan Adult Leukemia Study Group].
    Miyawaki S, Tanimoto M, Kobayashi T, Minami S, Tamura J, Omoto E, Kuriyama K, Hatake K, Saito K, Ohno R.
    Gan To Kagaku Ryoho; 2000 Jul 15; 27(8):1160-7. PubMed ID: 10945011
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Induction chemotherapy for newly diagnosed acute myeloid leukaemia using a regime containing cytosine arabinoside, daunorubicin and etoposide.
    Liang R, Chiu E, Chan TK, Todd D.
    Cancer Chemother Pharmacol; 1990 Jul 15; 26(5):380-2. PubMed ID: 2208581
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Survival in 91 adults with acute myelogenous leukaemia treated with 1-6 intensive courses of chemotherapy.
    Evensen SA, Brinch L, Stavem P, Tjønnfjord G.
    J Intern Med; 1992 Nov 15; 232(5):433-7. PubMed ID: 1453128
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.